467 related articles for article (PubMed ID: 17588934)
1. An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site.
Rock FL; Mao W; Yaremchuk A; Tukalo M; Crépin T; Zhou H; Zhang YK; Hernandez V; Akama T; Baker SJ; Plattner JJ; Shapiro L; Martinis SA; Benkovic SJ; Cusack S; Alley MR
Science; 2007 Jun; 316(5832):1759-61. PubMed ID: 17588934
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles.
Seiradake E; Mao W; Hernandez V; Baker SJ; Plattner JJ; Alley MR; Cusack S
J Mol Biol; 2009 Jul; 390(2):196-207. PubMed ID: 19426743
[TBL] [Abstract][Full Text] [Related]
3. Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690.
Zhou XL; Tan M; Wang M; Chen X; Wang ED
Biochem J; 2010 Sep; 430(2):325-33. PubMed ID: 20557293
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the interaction of benzoxaborole inhibitor AN2690 with connective polypeptide 1 (CP1) editing domain of
Tandon S; Manhas R; Tiwari N; Munde M; Vijayan R; Gourinath S; Muthuswami R; Madhubala R
J Biosci; 2020; 45():. PubMed ID: 32385222
[TBL] [Abstract][Full Text] [Related]
5. Characterization of benzoxaborole-based antifungal resistance mutations demonstrates that editing depends on electrostatic stabilization of the leucyl-tRNA synthetase editing cap.
Sarkar J; Mao W; Lincecum TL; Alley MR; Martinis SA
FEBS Lett; 2011 Oct; 585(19):2986-91. PubMed ID: 21856301
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Resistance Mechanism of a Benzoxaborole Inhibitor Reveals Insight into the Leucyl-tRNA Synthetase Editing Mechanism.
Zhao H; Palencia A; Seiradake E; Ghaemi Z; Cusack S; Luthey-Schulten Z; Martinis S
ACS Chem Biol; 2015 Oct; 10(10):2277-85. PubMed ID: 26172575
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.
Baker SJ; Zhang YK; Akama T; Lau A; Zhou H; Hernandez V; Mao W; Alley MR; Sanders V; Plattner JJ
J Med Chem; 2006 Jul; 49(15):4447-50. PubMed ID: 16854048
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent, reversible, oxaborole inhibition of Escherichia coli leucyl-tRNA synthetase measured with a continuous fluorescence assay.
Shapiro AB; Gao N; Hajec L; McKinney DC
Anal Biochem; 2012 Dec; 431(1):48-53. PubMed ID: 22975201
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on targeting aminoacyl-tRNA synthetases for the treatment of fungal infections.
Ferrer E
Drug News Perspect; 2006; 19(6):347-8. PubMed ID: 16971970
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase.
Manhas R; Tandon S; Sen SS; Tiwari N; Munde M; Madhubala R
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941647
[TBL] [Abstract][Full Text] [Related]
11. Two tyrosine residues outside the editing active site in Giardia lamblia leucyl-tRNA synthetase are essential for the post-transfer editing.
Zhou XL; Wang ED
Biochem Biophys Res Commun; 2009 Aug; 386(3):510-5. PubMed ID: 19540202
[TBL] [Abstract][Full Text] [Related]
12. A conserved threonine within Escherichia coli leucyl-tRNA synthetase prevents hydrolytic editing of leucyl-tRNALeu.
Mursinna RS; Lincecum TL; Martinis SA
Biochemistry; 2001 May; 40(18):5376-81. PubMed ID: 11331000
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase Inhibitors.
Si Y; Basak S; Li Y; Merino J; Iuliano JN; Walker SG; Tonge PJ
ACS Infect Dis; 2019 Jul; 5(7):1231-1238. PubMed ID: 31007018
[TBL] [Abstract][Full Text] [Related]
14. A viable amino acid editing activity in the leucyl-tRNA synthetase CP1-splicing domain is not required in the yeast mitochondria.
Karkhanis VA; Boniecki MT; Poruri K; Martinis SA
J Biol Chem; 2006 Nov; 281(44):33217-25. PubMed ID: 16956879
[TBL] [Abstract][Full Text] [Related]
15. Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase.
Palencia A; Liu RJ; Lukarska M; Gut J; Bougdour A; Touquet B; Wang ED; Li X; Alley MR; Freund YR; Rosenthal PJ; Hakimi MA; Cusack S
Antimicrob Agents Chemother; 2016 Oct; 60(10):5817-27. PubMed ID: 27431220
[TBL] [Abstract][Full Text] [Related]
16. A paradigm shift for the amino acid editing mechanism of human cytoplasmic leucyl-tRNA synthetase.
Pang YL; Martinis SA
Biochemistry; 2009 Sep; 48(38):8958-64. PubMed ID: 19702327
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase.
Hu QH; Liu RJ; Fang ZP; Zhang J; Ding YY; Tan M; Wang M; Pan W; Zhou HC; Wang ED
Sci Rep; 2013; 3():2475. PubMed ID: 23959225
[TBL] [Abstract][Full Text] [Related]
18. Mutational unmasking of a tRNA-dependent pathway for preventing genetic code ambiguity.
Williams AM; Martinis SA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3586-91. PubMed ID: 16505383
[TBL] [Abstract][Full Text] [Related]
19. Interdomain communication modulates the tRNA-dependent pre-transfer editing of leucyl-tRNA synthetase.
Tan M; Zhu B; Liu RJ; Chen X; Zhou XL; Wang ED
Biochem J; 2013 Jan; 449(1):123-31. PubMed ID: 23035846
[TBL] [Abstract][Full Text] [Related]
20. Modular pathways for editing non-cognate amino acids by human cytoplasmic leucyl-tRNA synthetase.
Chen X; Ma JJ; Tan M; Yao P; Hu QH; Eriani G; Wang ED
Nucleic Acids Res; 2011 Jan; 39(1):235-47. PubMed ID: 20805241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
